Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Astria Therapeutics, Inc. (ATXS) had Return on Investments of -42.09% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-94.26M |
|
-- |
|
-- |
|
$111.56M |
|
$-111.56M |
|
$17.30M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-111.56M |
|
$-111.56M |
|
56.16M |
|
56.16M |
|
$-1.68 |
|
$-1.68 |
|
| Balance Sheet Financials | |
$334.64M |
|
-- |
|
$7.72M |
|
$342.36M |
|
$19.13M |
|
-- |
|
$99.29M |
|
$118.42M |
|
$223.94M |
|
$223.94M |
|
$223.94M |
|
56.43M |
|
| Cash Flow Statement Financials | |
$-81.21M |
|
$-191.86M |
|
$157.20M |
|
$175.69M |
|
$59.82M |
|
$-115.87M |
|
$13.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.09% |
|
-42.09% |
|
-27.53% |
|
|
Return on Investments |
-42.09% |
$3.97 |
|
$-1.45 |
|
$-1.45 |
|